Duration of survival and quality of life are important factors that both patients and physicians consider. Current studies have used artificial neural networks to consider a variety of factors to quantify survival outcomes in patients with cancer, gastrointestinal bleeding, and inflammatory bowel disease.

Artificial neural networks (AI) belong to a sub-category of artificial intelligence and have been used in many sub-specialties of clinical medicine, including pathology, radiology, cardiology, neurology, orthopedics, and gastroenterology. So what are the limitations and challenges of AI in the future of medicine?